Journal: Life
Article Title: Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease
doi: 10.3390/life13051213
Figure Lengend Snippet: Exemplary cardiac magnetic resonance images of a Fabry disease patient with pronounced left ventricular hypertrophy ( a ) and an extensive area of late gadolinium enhancement ( b ).
Article Snippet: LVMi, interventricular septal thickness (IVS), posterior wall thickness (PWT), left ventricular ejection fraction (EF), end-diastolic volume (EDV), ejection fraction (EF), late gadolinium enhancement (LGE) and septal T1 relaxation times before the application of the contrast medium were measured using specific CMR post-processing software (Medis Suite MR, Medis Medical Imaging, Leiden, Netherlands or Syngovia, Siemens Healthcare, Erlangen, Germany) according to current guidelines [ ].
Techniques: